• Profile
Close

Prediagnostic serum 25-hydroxyvitamin D and mortality among bladder cancer patients in the Janus Serum Bank Cohort

Clinical Epidemiology Sep 17, 2021

Hektoen HH, Gislefoss RE, Stenehjem JS, et al. - Findings indicate that vitamin D deficiency has a more critical role in an early stage of urothelial bladder cancer (BC).

  • From 378 BC patients within the population-based Janus Cohort, prediagnostic serum were used.

  • Hzard ratios (HRs), with 95% confidence intervals (CIs), were estimated.

  • An elevated risk of BC-specific mortality (HR 1.87, 95% CI 1.10– 3.20) was observed in relation to the presence of 25-hydroxyvitamin D (25(OH)D) deficiency (< 50 nmol/L) prior to a BC diagnosis, vs insufficient levels (50– 74 nmol/L).

  • The findings were evident among non-muscle invasive BC cases only.

  • There was no link between 25(OH)D levels and all-cause mortality in cancer-free controls.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay